425 results on '"Axelrad, Jordan E"'
Search Results
2. Tofacitinib Uptake by Patient-Derived Intestinal Organoids Predicts Individual Clinical Responsiveness
3. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary
4. Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn’s Disease
5. Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry
6. S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes
7. Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study
8. The γδ IEL effector API5 masks genetic susceptibility to Paneth cell death
9. Cancer in Inflammatory Bowel Disease
10. Tofacitinib Uptake by Patient-Derived Intestinal Organoids Predicts Individual Clinical Responsiveness.
11. Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years.
12. A Prediction Model Incorporating Peripheral Eosinopenia as a Novel Risk Factor for Death After Hospitalization for Clostridioides difficile Infection
13. A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease
14. PATHOGEN-SPECIFIC ALTERATIONS IN THE GUT MICROBIOTA PREDICT OUTCOMES IN FLARE OF INFLAMMATORY BOWEL DISEASE COMPLICATED BY GASTROINTESTINAL INFECTION
15. Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia
16. Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes
17. Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses
18. Ustekinumab and Vedolizumab Are Not Associated With Subsequent Cancer in IBD Patients with Prior Malignancy
19. Endoscopic Algorithm for Management of Gastrointestinal Bleeding in Patients With Continuous Flow LVADs: A Prospective Validation Study
20. Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases
21. Tofacitinib uptake by patient-derived intestinal organoids predicts individual clinical responsiveness
22. The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease
23. S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes
24. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia
25. The Role of the Radiologist in Determining Disease Severity in Inflammatory Bowel Diseases
26. Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case–Control Study
27. Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn’s Disease
28. Comparative Evaluation of Conventional Stool Testing and Multiplex Molecular Panel in Outpatients With Relapse of Inflammatory Bowel Disease
29. Limited usefulness of endoscopic evaluation in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding
30. From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area
31. Atherosclerosis as a Risk Factor of Inflammatory Bowel Disease: A Population-Based Case-Control Study.
32. Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease
33. Inflammatory Bowel Disease and Risk of Colorectal Polyps: A Nationwide Population-Based Cohort Study From Sweden
34. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies
35. Gastrointestinal Infections in IBD Flares: Can PCR-Based Stool Tests Differentiate the Smoke from the Fire?
36. Increased Healthcare Utilization by Patients With Inflammatory Bowel Disease Covered by Medicaid at a Tertiary Care Center
37. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile
38. Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease
39. sj-docx-1-tag-10.1177_17562848231158231 – Supplemental material for Risk factors for incomplete telehealth appointments among patients with inflammatory bowel disease
40. Differences by transplant type in stool multiplex PCR testing for acute diarrhea in post-solid organ transplantation
41. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies
42. Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop
43. Diagnosis and Monitoring of Ulcerative Colitis
44. Treatment of Crohn’s Disease Anastomotic Stricture With a Lumen-apposing Metal Stent
45. Inflammatory Bowel Disease and Risk of Colorectal Polyps: A Nationwide Population-Based Cohort Study From Sweden.
46. Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn’s Disease Following Ileocecal Resection
47. Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.
48. Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
49. Effects of Cancer Treatment on Inflammatory Bowel Disease Remission and Reactivation
50. Editorial: safety in numbers—cycling of biologics does not increase risk of adverse outcomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.